Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Corneal Collagen Cross-linking Using Two Different Techniques.

NCT01708538 is registered in ClinicalTrials.gov with Rush Eye Associates as lead sponsor.

NCT NCT01708538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01708538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Corneal Collagen Cross-linking Using Two Different Techniques.
Lead sponsor
Rush Eye Associates
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2012
Completion date
October 31, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corneal ectasia disorders including keratoconus